Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Oct;2(10):a003236.
doi: 10.1101/cshperspect.a003236. Epub 2010 Aug 18.

Oncogenes and tumor suppressor genes

Eva Y H P Lee  1 , William J Muller
Affiliations
Review

Oncogenes and tumor suppressor genes

Eva Y H P Lee et al. Cold Spring Harb Perspect Biol. 2010 Oct.

Abstract

Breast cancer progression involves multiple genetic events, which can activate dominant-acting oncogenes and disrupt the function of specific tumor suppressor genes. This article describes several key oncogene and tumor suppressor signaling networks that have been implicated in breast cancer progression. Among the tumor suppressors, the article emphasizes BRCA1/2 and p53 tumor suppressors. In addition to these well characterized tumor suppressors, the article highlights the importance of PTEN tumor suppressor in counteracting PI3K signaling from activated oncogenes such as ErbB2. This article discusses the use of mouse models of human breast that recapitulate the key genetic events involved in the initiation and progression of breast cancer. Finally, the therapeutic potential of targeting these key tumor suppressor and oncogene signaling networks is discussed.

PubMed Disclaimer

References

    1. Ackler S, Ahmad S, Tobias C, Johnson MD, Glazer RI 2002. Delayed mammary gland involution in MMTV-AKT1 transgenic mice. Oncogene 21: 198–206 - PubMed
    1. Adelsman MA, McCarthy JB, Shimizu Y 1999. Stimulation of β1-integrin function by epidermal growth factor and heregulin-β has distinct requirements for ErbB2 but a similar dependence on phosphoinositide 3-OH kinase. Mol Biol Cell 10: 2861–2878 - PMC - PubMed
    1. Allred DC, Clark GM, Molina R, Tandon AK, Schnitt SJ, Gilchrist KW, Osborne CK, Tormey DC, McGuire WL 1992. Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Hum Pathol 23: 974–979 - PubMed
    1. Andrechek ER, White D, Muller WJ 2005. Targeted disruption of ErbB2/Neu in the mammary epithelium results in impaired ductal outgrowth. Oncogene 24: 932–937 - PubMed
    1. Andrechek ER, Hardy WR, Siegel PM, Rudnicki MA, Cardiff RD, Muller WJ 2000. Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. Proc Natl Acad Sci 97: 3444–3449 - PMC - PubMed